Dynavax Technologies (DVAX) 10-Q2012 Q1 Quarterly report

Content analysis

Filed: 4 May 12, 12:00am

Date: May 4, 2012

/s/ JENNIFER LEW

Jennifer Lew

Vice President, Finance
(Principal Accounting and Financial Officer)

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Absent, absolute, accomplish, Addressing, attached, aware, Biogen, breach, commensurate, converged, desired, duly, encounter, entry, exhibit, expansion, faith, February, growing, healthcare, hire, Idec, inclusion, inflammation, insolvency, Instance, integrate, interactive, irrespective, joint, Junior, language, Likewise, Linkbase, matter, Mellon, multiplied, November, processed, promptly, recombinant, reference, repaid, Restated, Schema, senior, shelf, Street, Taxonomy, thereunto, thirty, Topic, toxicology, train, uncured, undersigned, unnecessary, unrealized, variance, Wall, warrant, window, wording, XBRL

Removed: accreted, affiliate, agonist, agree, Allergy, appointed, arithmetic, assumed, audit, automatically, Baylor, beginning, beneficially, beta, biology, cancer, charged, closed, collectively, commencement, committed, continuation, customary, Daniel, Deerfield, delisted, demonstrate, demonstrating, deplete, derive, designee, directing, direction, discontinuation, discounted, discussed, dissolution, dose, doubt, ending, enroll, escalating, execute, execution, explore, extend, feasibility, fee, Finally, fourth, free, fully, goodwill, Hansenula, HBV, healthy, HPV, immaterial, Immunology, IND, indemnification, individual, influence, initiating, Institute, institutional, Kessel, Kisner, larger, leased, liquidate, liquidation, lowest, Mark, month, mutually, National, netted, nominated, open, ordinary, originally, papilloma, partnering, passage, peer, percentage, pertaining, Phenotyping, power, promissory, rapid, ratably, realization, realize, recoverability, reduction, reflect, reflected, removal, removed, requirement, respond, responsive, rheumatoid, safe, satisfaction, secure, settlement, show, SLE, space, Standstill, study, superior, test, thousand, threshold, transferred, viable, wind, working, yeast

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

DVAX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

I, Jennifer Lew, hereby certify, pursuant to 18 U.S.C § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, in my capacity as an officer of Dynavax Technologies Corporation (the “Company”), that, to the best of my knowledge:

(i)

The Quarterly Report of the Company on Form 10-Q for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934, as amended (“the Exchange Act”); and

(ii)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 of the Public Company Accounting Reform and Investor Protection Act of 2002 (18 U.S.C. § 1350, as adopted) has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission (“SEC”) or its staff upon request. This certification “accompanies” the Form 10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.